Table 1.
Cirrhosis (n = 48) | No Cirrhosis (n = 478) | p value | |
---|---|---|---|
Demog2raphics | |||
Age, years – mean (±SD) | 58.94 (±11.01) | 57.60 (±15.79) | 0.567 |
0.031 | |||
Male Gender – n (%) | 19 (39.58) | 267 (55.86) | |
Ethnicity – n (%) | 0.269 | ||
Hispanic | 25 (52.08) | 253 (52.93) | |
African American | 12 (25.00) | 148 (30.96) | |
Caucasian | 7 (14.58) | 33 (06.90) | |
Others | 4 (08.33) | 44 (09.21) | |
Associated comorbidities – n (%) | |||
Hypertension | 38 (79.17) | 337 (70.65) | 0.213 |
Diabetes mellitus | 26 (54.17) | 262 (54.9) | 0.92 |
ESRD | 5 (10.42) | 63 (13.21) | 0.583 |
CHF | 11 (22.92) | 156 (32.70) | 0.165 |
Presence of other infections – n (%) | |||
Sepsis | 21 (43.75) | 233 (48.85) | 0.501 |
Pneumonia | 25 (52.08) | 281 (58.91) | 0.361 |
Urinary tract infection | 15 (31.25) | 145 (30.40) | 0.903 |
Laboratory parameters – mean (±SD) | |||
WBC, k/ul | 17.61 (±14.20) | 15.73 (±/-9.52) | 0.222 |
Serum Albumin, g/dL | 3.46(+0.85) | 2.8(+0.7) | 0.001 |
BUN, mg/dl | 41.88 (±29.51) | 36.09 (±33.14) | 0.246 |
Serum Creatinine, mg/dl* | 1.1(3) | 1.75(3.3) | 0.273 |
Serum Potassium, mEq/L | 3.26 (±0.63) | 3.36 (±0.71) | 0.374 |
Serum Chloride, mEq/L | 92.07 (±15.39) | 95.25 (±8.76) | 0.029 |
Serum Bicarbonate, mEq/L | 15.04 (±5.44) | 17.43 (±5.53) | 0.005 |
Lactate, mmoles/L* | 2(±2) | 3.17 (±3.63) | 0.22 |
Outcome | |||
Mortality – n (%) | 19(39.6%) | 2.7(3) | 0.15 |
Length of Stay, days – median (IQR)* | 2 (6) | 2(5) | 0.0806 |
Notes: The above data is being presented using n (%) and mean ± standard deviation; *Continuous variable represented with Median (interquartile range) and comparison is made with the Mann–Whitney U-test.
Abbreviations: ESRD, end-stage renal disease; CHF, congestive heart failure; WBC, white blood cell; BUN, blood urea nitrogen.